Invesco’s Tempest Therapeutics TPST Stock Holding History

Invesco’s Portfolio TPST Stock Details TPST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-63	Closed	-$961K	–	3678
2016 Q2	$961K	Buy	+63	New	+$1.44M	﹤0.01%	2929
2015 Q3	–	Sell	-20	Closed	-$1.73M	–	3983
2015 Q2	$1.73M	Sell	20 -5	-20%	-$458K	﹤0.01%	2731
2015 Q1	$2.49M	Buy	25 +6	+32%	+$799K	﹤0.01%	2457
2014 Q4	$2.46M	Sell	19 -13	-41%	-$952K	﹤0.01%	2397
2014 Q3	$1.53M	Buy	+32	New	+$1.12M	﹤0.01%	2700

Other funds holding TPST

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco's TPST Position: Q3 2016 in Review

Invesco sold out of Tempest Therapeutics (TPST) in Q3 2016, closing a stake of 63 shares — an estimated $961K sold.

Invesco first reported a position in TPST in Q3 2014 and held it in 5 quarters. The position peaked at $2.49M in Q1 2015. 80 funds tracked by Wall St. Rank hold TPST as of Q3 2016.

Invesco reported no remaining Tempest Therapeutics position as of Q3 2016 after selling out during the quarter.
Invesco sold 63 Tempest Therapeutics shares in Q3 2016, an estimated $961K.
Invesco first reported a position in Tempest Therapeutics in Q3 2014 and held it in 5 quarters.
Invesco's Tempest Therapeutics position peaked at $2.49M in Q1 2015.
80 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q3 2016.

Based on Invesco's 13F filing for Q3 2016, filed 14 Nov 2016.